A view on technology and innovation stocks, whether they will thrive or struggle, after the world has received Covid-19 vaccination.

The fruitfulness of returns in technology and innovation stocks is so high to the extent that domestic mutual funds invest a lot in this sector. It is able to generate more than 30% of returns on each fund. If we look at the financial statements of the listed companies, it will be found that their revenues have risen, especially in the electronic component sector, which has grown significantly. Despite competing with Vietnam, the potential and production technology of Thailand, which has long been the production base for leading companies, is still reliable and trusted. This is in line with the report of the Board of Investment (BOI) indicating that the No. 1 investment promotion application in 2020 was electrical appliances and electronics, with an investment value of 50.3 billion baht. Equally remarkable is the medical industry, especially in the area of ​​innovation in drug and vaccine manufacturing, which has been promoted by leapfrogging. Since Thailand has been entrusted as a foreign production base for the COVID-19 vaccine, it shows that Thailand still has the potential and the competitiveness and investment.